SEC 13F Intelligence

Piershale Financial Group, Inc. / MRNA

Piershale Financial Group, Inc.’s Moderna Inc Position

Does Piershale Financial Group, Inc. own Moderna Inc (MRNA)? Not currently — the last reported position was 10.3K shares worth $4M in Q3 2021; the fund’s latest 13F (Q2 2023) no longer reports it.

Position Value
$4M
Q3 2021
Shares
10.3K
% of Portfolio
+1.63%
Quarters Held
1
position exited

Position History MRNA

Reported value by quarter
Q3 ’21: $4MQ3 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q3 202110.3K$4M+1.63%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Piershale Financial Group, Inc.’s full portfolio or all institutional holders of MRNA.